Future of Blood Banking Market: Growth Opportunities and Business Expansion Strategies

Dec. 6, 2011 - PRLog -- Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to add a new report to its collection of Diagnostics Market Research and Technology Assessments publications.

"Future of Blood Banking Market: Growth Opportunities and Business Expansion Strategies" (http://www.vpgmarketresearch.com/blood-banking.html) is a seven-country, 800-page report designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the blood banking market during this decade.

To review or order this report, visit http://www.vpgmarketresearch.com/The-BloodBanking-Market.html

Contact

Robert Fisher
Healthcare Research
robert@vpgcorp.com
+1 212 564 2838
http://www.VPGMarketResearch.com

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next ten years, and assist industry executives in developing effective business, new product development and marketing strategies.  

The report explores future marketing and technological trends in the US, Europe and Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.

Sales and Market Share Analysis

Sales and market share estimates for leading
suppliers of blood banking reagents
and instruments, by country and individual
product.

Instrument Placements

Annual placements and installed base of
major automated and semi-automated
analyzers, by supplier and model.

Competitive Assessments

Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new
products in R&D.

Market Segmentation Analysis

- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,
and key suppliers, by country.

- Test volume and sales forecasts for over 40
blood banking tests, including NAT,
by country and market segment:

- Blood Centers
- Plasma Fractionation Facilities
- Hospitals
- Commercial/Private Laboratories
- Military Blood Banks

Current and Emerging Products

- Analysis of current and emerging blood banking
tests.

- Review of automated and semi-automated
analyzers, including their operating
characteristics, features, and selling prices.

Technology Review

- Assessment of current and emerging
technologies, and their potential applications
for the blood banking market.

- Comprehensive lists of companies developing
or marketing new technologies and products, by test.

Worldwide Market Overview

- Estimates of facilities performing blood banking
tests, by country.

- Test volume and sales projections by country.

Strategic Recommendations

- New product development
opportunities with significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Methodology

The report is based on combination of primary and secondary information sources, including interviews with blood bankers, laboratory directors, and executives of leading diagnostics companies in the U.S., five major European countries, and Japan.

In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.                  

Contains 800 pages and 240 tables

Table of Contents

I. Introduction

II. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. Infectious Disease Screening Tests
a. AIDS
b. Hepatitis
c. Cytomegalovirus
d. Syphilis
e. West Nile Virus
f. Parvovirus B19
g. Creutzfeldt-Jakob’s Disease
h. Malaria
i. Chagas Disease
j. Babesiosis
3. Pathogen Reduction
4. Leukocyte Reduction
- Background
- Methods
B. Instrumentation Review
Introduction
1. Abbott Architect i2000 Series
2. Abbott AxSYM
3. Abbott LCx
4. Abbott Prism
5. Abbott Quantum II
6. Beckman Coulter/Biomek FX
7. Beckman Coulter BloodTrack Courier
8. Beckman Coulter OLA2500
9. Beckman Coulter PK7100
10. Beckman Coulter PK7200
11. Beckman Coulter PK80
12. Beckman Coulter Tango
13. Bio-Rad Elite
14. Bio-Rad GeneScope
15. BioMerieux Bac/Alert
16. Gen-Probe Tigris
17. Grifols Diana
18. Immucor ABS2000
19. Immucor Galileo
20. Immucor Rosys Plato System
21. Nanosphere Verigen Series
22. Ortho AutoVue/ProVue
23. Ortho StarFame Combo
24. Ortho Summit Processor
25. Roche Cobas Amplicor
26. Roches Cobas s 201
27. Sarstedt PVS
28. Siemens BEP 2000
29. Siemens Quadriga
30. Siemens SDA
31. Tecan ELPHAtyper
32. Tecan Genesis FE500
33. Tecan Hemotyper
34. Tecan LS Series
35. Tecan MegaFlex
36. Tecan MiniSwift
C. Major in Vitro Diagnostic Technologies
And Their Potential Applications
1. Molecular Diagnostics
a. Overview
b. NAT
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Enzyme Amplification
c. Fluorescent Immunoassays
- Fluorescence Polarization
d. Luminescence
- Chemiluminescence
- Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Microtitration Plates
5. Information Technology
6. Automation
7. Lasers
8. Robotics
9. Artificial Intelligence
10. Synthetic Red Cell Substitutes
11. Genetically Engineered Blood Components
a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand's Factor
g. Fibrinogen
h. t-PA
12. Blood Preservation
13. Autologous Blood Transfusion/Freezing

D. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
France
Germany
Italy
Japan
Spain
U.K.
U.S.A.

Competitive Assessments
- Abbott
- Beckman Coulter
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio
- Gen-Probe
- Grifols
- Immucor
- Innogenetics
- Ortho-Clinical Diagnostics
- Orchid CellMark
- Novartis Diagnostics
- Proteome Sciences
- Roche
- Siemens
- Tecan

Contact

Robert Fisher
Healthcare Research
robert@vpgcorp.com
+1 212 564 2838
http://www.VPGMarketResearch.com

# # #

Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the Diagnostics, Pharmaceutical, Imaging, Orthopedics, Biotechnology, Chemical, Flavors & Fragrances, Food & Beverage, Electronics, and other industries.

During numerous proprietary single-client consulting assignments and over 500 multiclient studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide.

VPG has served over 1,000 corporations in 70 countries, and has established a broad network of worldwide contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.